Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure Nangaku MIntern Med 2004[Jan]; 43 (1): 9-17There are many different glomerular disorders, including glomerulonephritis, diabetic nephropathy, and hypertensive nephrosclerosis. However, once glomerular damage reaches a certain threshold, the progression of renal disease is consistent and irreversible. Recent studies emphasized the crucial role of tubulointerstitial injury as a mediator of progression of kidney disease. One common mechanism that leads to renal failure via tubulointerstitial injury is massive proteinuria. Accumulating evidence suggests critical effects of filtered macromolecules on tubular cells, including lysosomal rupture, energy depletion, and tubular injury directly induced by specific components such as complement components. Another common mechanism is chronic hypoxia in the tubulointerstitium. Tubulointerstitial damage results in the loss of peritubular capillaries, impairing blood flow delivery. Interstitial fibrosis also impairs oxygen diffusion and supply to tubular cells. This induces chronic hypoxia in this compartment, rendering a vicious cycle. Development of novel therapeutic approaches against these final common pathways will enable us to target any types of renal disease.|Adult[MESH]|Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH]|Biopsy, Needle[MESH]|Complement Membrane Attack Complex/metabolism[MESH]|Disease Progression[MESH]|Female[MESH]|Humans[MESH]|Hypoxia/complications/diagnosis[MESH]|Immunohistochemistry[MESH]|Kidney Failure, Chronic/*etiology/physiopathology[MESH]|Kidney Function Tests[MESH]|Kidney Tubules/drug effects/pathology[MESH]|Male[MESH]|Middle Aged[MESH]|Nephritis, Interstitial/*complications/drug therapy/*pathology[MESH]|Prognosis[MESH]|Proteinuria/*complications/diagnosis[MESH]|Risk Factors[MESH]|Severity of Illness Index[MESH] |